Réactifs et instruments pour l'immunologie, la biologie cellulaire et la biologie moléculaire.
 
> BABY Rabbit COMPLEMENT Serum & Cells

BABY Rabbit COMPLEMENT Serum & Cells

Imprimer Imprimer
Identifiez-vous

Référence OOSA10423

Conditionnement : 1ml

Marque : Aviva Systems Biology

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

    Datasheets/ManualsPrintable datasheet for BABY Rabbit COMPLEMENT Serum & Cells (OOSA10423)
    Product Info
    Predicted Species ReactivityRabbit
    Product FormatLyophilized
    ApplicationFC
    Reconstitution and Storage2°C to 8°C|-80°C
    SpecificityThis rabbit serum is intended for use as a source of rabbit complement for cytotoxicity studies.
    Reference1. Council of Europe. (1983) Essential aspects of tissue typing: Preparation, use, storage of reagents and standardisation of complement. European Health Committee, Strasbourg, ISBN 92-871.224-4.
    2. Edited by J.G.Ray. (1979) NIAID Manual of tissue typing techniques . Publication No. NIH-80-545.
    3. Anderson. L.D. Jr, et al. (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogenic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res. 59: 1525-1530.
    4. Mason. J. et al. (2002) Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ.Res. 91: 969-703.
    5. Lidington. E. et al. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement mediated injury. Blood. 96: 2784-2972.
    6. De Clerq. L. et al. (1997) An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue. J.Anim. Sci. 75: 1791-1797.
    Description of TargetBABY RABBIT COMPLEMENT